January 30, 2019
Rose
The details came out at the federal trial of Insys founder John Kapoor and four other former executives. On the first day of testimony, prosecutors sought to grab jurors’ attention with racy details about the lengths to which Insys officials would allegedly go to market its opioid-spray Subsys for off-label use among doctors. Meanwhile, federal money is helping advocates win victories against the opioid epidemic in the states, but they say more is needed.
from Kaiser Health News http://bit.ly/2sUmxTF
January 30, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: Don’t Leave Behind Pain Patients While Fixing Opioid Crisis; Anti-Immigration Policies Threaten Health Care- Longer Looks: What Causes Sexual Assault; The Plan To End Measles; And A Food Science Crisis
- Perspectives: #WhyIDidn’tReport: Rape Culture ‘Very Much At Play’ In America Today
- State Highlights: Union Accuses Mass. Watchdog Overseeing Nursing Ballot Initiative Of Having Bias; Officials Confirm Case Of Legionnaire’s Disease At D.C. Senior Living Community
- Different Takes: Preexisting Conditions Protections Under Attack From Lawsuit, Conservative Supreme Court
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment